Ilya Pharma welcomes a new project manager to the team

Peter Frank now fills the position as Drug Development manager at Ilya Pharma. Peter has a background in the industry of more than fifteen years working with development of biologics. Previous recent positions were at GE Healthcare and Galderma.


Ilya Pharma is selected finalist for SwedenBIO Award 2018

SwedenBIO's prize is awarded to a Life Science company that demonstrated successful achievements beyond the usual and that has contributed to increased interest in the industry. This year Ilya Pharma is selected as finalist together with Bioarctic, Galenica, Gedea Biotech, Hansa Medical, Isconova/Novavax, Scandinavian Biopharma, Verigraft, Wilson Therapeutics and Xintela. The jury consists of SwedenBIO's Board and a representative of the year's price sponsor HealthCap.


Export in the hot spot

Evelina Vågesjö participated in a panel discussion with Ann Linde, Sweden´s Minister of EU affairs and trade. The subject was how to strengthen the export potential in the business region Uppsala.


Female entrepreneurs leading the way

Five promising entrepreneurs from the Nordic countries was selected to participate in a global conference in New York, between the 4th and 9th of March. The focus was how to build a sustainable global company according to the goals UN Development and Sustainability Objectives 2030.


Ilya Pharma is awarded three million euros from H2020 EU SME programme

Uppsala-based Ilya Pharma has been awarded EUR 2.99 million (about SEK 30 million) from the European Commission in the face of tough international competition. The company, which develops next-generation biological drugs for treating wounds in skin and mucous membranes, has thus secured funding to obtain the first clinical data for its new drug candidate.